• Popular
    • Medicine
    • Radiology
    • Cardiology
    • Surgery
    • Nanomedicine
    • Military Medicine
    • Rehab
  • Categories
    • Exclusive
    • A-D
      • Anesthesiology
      • Art
      • Cardiac Surgery
      • Cardiology
      • Critical Care
      • Dentistry
      • Dermatology
      • Diagnostics
    • E-I
      • Emergency Medicine
      • ENT
      • Genetics
      • Geriatrics
      • GI
      • Informatics
    • M-N
      • Medicine
      • Military Medicine
      • Nanomedicine
      • Net News
      • Neurology
      • Neurosurgery
      • Nuclear Medicine
    • O-P
      • Ob/Gyn
      • Oncology
      • Ophthalmology
      • Orthopedic Surgery
      • Pathology
      • Pediatrics
      • Plastic Surgery
      • Psychiatry
      • Public Health
    • R-V
      • Radiation Oncology
      • Radiology
      • Rehab
      • Reproductive Medicine
      • Space Medicine
      • Sports Medicine
      • Surgery
      • Thoracic Surgery
      • Urology
      • Vascular Surgery
  • SUBSCRIBE
  • Submit PR
  • About
  • Follow
    • Facebook
    • Twitter
    • Linkedin
    • Youtube
    • Instagram
    • RSS
  • Submit PR
  • Log in
Medgadget
Medgadget
  • Popular
    • Medicine
      Cancer Organoids Offer Insights into Treatment Outcomes

      Cancer Organoids Offer Insights into Treatment Outcomes

      Cell Culture Chamber Mimics Mechanical States of Disease

      Cell Culture Chamber Mimics Mechanical States of Disease

      Laser-Based Breath Analysis Detects COVID-19 Infection

      Laser-Based Breath Analysis Detects COVID-19 Infection

      Technique Reveals 3D Genome Interactions

      Technique Reveals 3D Genome Interactions

    • Radiology
      Implanted Ultrasound Lets Chemo Access Brain

      Implanted Ultrasound Lets Chemo Access Brain

      Wearable Ultrasound Measures Tissue Stiffness Under Skin

      Wearable Ultrasound Measures Tissue Stiffness Under Skin

      Brain Decoder Spells Out Thoughts

      Brain Decoder Spells Out Thoughts

      RF Technology for Health Monitoring: Michael Leabman, CTO of Movano Health

      RF Technology for Health Monitoring: Michael Leabman, CTO of Movano Health

    • Cardiology
      Cell Culture Chamber Mimics Mechanical States of Disease

      Cell Culture Chamber Mimics Mechanical States of Disease

      Chest Wearable Provides Key Heart Measurements

      Chest Wearable Provides Key Heart Measurements

      Vein on a Chip Includes Flexible Valves

      Vein on a Chip Includes Flexible Valves

      Knitted Glove Massages the Hand to Treat Edema

      Knitted Glove Massages the Hand to Treat Edema

    • Surgery
      Automated Computer Assistant for Kidney Transplant Rejection Diagnostics: Interview with Study Authors

      Automated Computer Assistant for Kidney Transplant Rejection Diagnostics: Interview with Study Authors

      Soft Robotic Electrode Enables Minimally Invasive Placement

      Soft Robotic Electrode Enables Minimally Invasive Placement

      Wound Dressing Detects Infection, Changes Color

      Wound Dressing Detects Infection, Changes Color

      Stimulating Wounds with Electricity for Rapid Healing

      Stimulating Wounds with Electricity for Rapid Healing

    • Nanomedicine
      Bottlebrush Nanoparticles Deliver Immunostimulatory Drugs

      Bottlebrush Nanoparticles Deliver Immunostimulatory Drugs

      Nanoparticles Deliver mRNA Therapy to the Lungs

      Nanoparticles Deliver mRNA Therapy to the Lungs

      Nanoparticles Get Lymphatic Vessels Pumping

      Nanoparticles Get Lymphatic Vessels Pumping

      Bottlebrush Particle for Synergistic Drug Combinations

      Bottlebrush Particle for Synergistic Drug Combinations

    • Military Medicine
      Wearable Can Take Multiple Sweat Samples

      Wearable Can Take Multiple Sweat Samples

      Wound Dressing Detects Infection, Changes Color

      Wound Dressing Detects Infection, Changes Color

      Device Measures Hemoglobin More Accurately in Dark Skin

      Device Measures Hemoglobin More Accurately in Dark Skin

      Fingertip Sensor Measures Lithium Levels in Sweat

      Fingertip Sensor Measures Lithium Levels in Sweat

    • Rehab
      Brain Decoder Spells Out Thoughts

      Brain Decoder Spells Out Thoughts

      Knitted Glove Massages the Hand to Treat Edema

      Knitted Glove Massages the Hand to Treat Edema

      Empowering Stroke Survivors: Interview with Kirsten Carroll, CEO at Kandu Health

      Empowering Stroke Survivors: Interview with Kirsten Carroll, CEO at Kandu Health

      Smart Walking Stick for Visually Impaired People

      Smart Walking Stick for Visually Impaired People

  • Categories
    • Exclusive
    • A-D
      • Anesthesiology
      • Art
      • Cardiac Surgery
      • Cardiology
      • Critical Care
      • Dentistry
      • Dermatology
      • Diagnostics
    • E-I
      • Emergency Medicine
      • ENT
      • Genetics
      • Geriatrics
      • GI
      • Informatics
    • M-N
      • Medicine
      • Military Medicine
      • Nanomedicine
      • Net News
      • Neurology
      • Neurosurgery
      • Nuclear Medicine
    • O-P
      • Ob/Gyn
      • Oncology
      • Ophthalmology
      • Orthopedic Surgery
      • Pathology
      • Pediatrics
      • Plastic Surgery
      • Psychiatry
      • Public Health
    • R-V
      • Radiation Oncology
      • Radiology
      • Rehab
      • Reproductive Medicine
      • Space Medicine
      • Sports Medicine
      • Surgery
      • Thoracic Surgery
      • Urology
      • Vascular Surgery
  • SUBSCRIBE
  • Submit PR
  • About
  • Log in
  • Submit PR
  • Follow
    • Facebook
    • Twitter
    • Linkedin
    • Youtube
    • Instagram
    • RSS

Alzheimer Drugs Market 2020- Global Industry Analysis, By Key Players, Segmentation, Trends and Forecast By 2026

March 9th, 2020 WISEGUY RESEARCH CONSULTANTS PVT LTD Releases

Summary:

A new market study, titled “Discover Global Alzheimer Drugs Market Upcoming Trends, Growth Drivers and Challenges” has been featured on WiseGuyReports.

Introduction

Global Alzheimer Drugs Market

WGR’s Alzheimer Drugs market perspectives provide a clear view of the data required to scrutinize the market predictions. It provides a broad platform for different companies, associations, manufacturers and suppliers who offer products and services to grow, compete and provide satisfactory service worldwide. The Alzheimer Drugs Market report offers comprehensive information on key competitors, as well as development organizations whose market value is significant in terms of sales, demand, demand ratio, sales, products, and services.

Alzheimer’s is the most common cause of dementia, a general term for memory loss and other cognitive abilities serious enough to interfere with daily life. Alzheimer’s disease accounts for 60 percent to 80 percent of dementia cases.

The increasing aging population and the majority of people with alzheimer are 65 years and older are the greatest risk factor for alzheimer diseases, approximately 200,000 Americans under the age of 65 have younger-onset alzheimer disease

The U.S. Food and Drug Administration (FDA) approved two types of medications, cholinesterase inhibitors (aricept, exelon, razadyne) and memantine (Namenda) to treat the cognitive symptoms (memory loss, confusion, and problems with thinking and reasoning) of alzheimer disease.

 

@Get Free Sample Report at https://www.wiseguyreports.com/sample-request/3792278-global-alzheimer-drugs-market-2018-2025

 

Market Drivers:

The increase in prevalence of alzheimer disease and aging population is driving the global alzheimer drugs market.

According to the U.S. Food and Drug Administration FDA, alzheimer disease is the 6th leading cause of death in the U.S. Due to Alzheimer the death rate have increased by 123% from 2000 to 2015. In 2017, 5.7 million Americans are living with Alzheimer By 2050, this number is projected to rise by nearly 14 million.

The number of Americans ages 65 and older was around 46 million in 2017 and it is projected to be 98 million by 2060. The 65-and-older age group’s share of the total population is expected to rise by 24% in 2060 from 15% in 2017.

High prices of advanced drugs, failing of investigational candidate in late stage, and awareness about alzheimer disease remains limited in developing countries might hamper the global alzheimer drugs market.

 

Market Segmentation

By Drug type

The global alzheimer drugs market is segmented based on drugs type, which include donepezil, galantamine, rivastigmine, and memantine. Memantine holds the major market share in 2017 and it is expected to remain dominant over the forecast period, due to the increasing approval of FDA for memantine.

Memantine is prescribed to improve memory, attention, reason, language and the ability to perform simple tasks. It can be used alone or with other alzheimer disease treatments.

Memantine (Namenda) and a combination of memantine and donepezil (Namzaric) are approved by the FDA for treatment of moderate to severe alzheimer.

For instance, in July 2016 Allergan plc and Adamas Pharmaceuticals, Inc. have received the FDA approval on new expanded label for NAMZARIC (memantine and donepezil hydrochlorides).

By geography

North America holds the major market share for alzheimer drugs in 2017, and it is expected to maintain the growth over the forecast period. It is due to the increasing clinical trials for phase II drug and phase III drugs in the U.S.

According to the FDA, there has been an 18% increase in phase II drugs (49 to 58) and a 7% increase in phase III drugs (30 to 32) for alzheimer disease in development from 2016 to 2017.

According to Alzheimer’s Association International Conference (AAIC) in July 2017, 27 alzheimer drugs in phase III clinical trials and 8 drugs in phase II clinical trials may launch in the next 5 years.

 

Competitive Landscape

The increase in strategic collaboration between companies for the development of alzheimer drugs is driving the global alzheimer drugs market.

For instance, in August 2015, Novartis entered into a global collaboration with Amgen to develop and commercialize pioneering treatments in the field of migraine and Alzheimer’s disease. The collaboration focuses on investigational Amgen drugs in the migraine field.

In November 2017, Novartis, Amgen and the Banner Alzheimer’s Institute (BAI) expanded collaboration to initiate a new trial, the Alzheimer Prevention Initiative (API) Generation Study 2. This trial follows the launch of the Generation Study 1, and will determine whether the BACE1 inhibitor CNP520 can prevent or delay the onset of Alzheimer disease symptoms in a high-risk population.

 

Why purchase the report?

  • Visualize the composition of the Alzheimer Drugs Market across each indication, in terms of drug type, and by distribution channel highlighting the key commercial assets and players.
  • Identify commercial opportunities in Alzheimer Drugs Market by analyzing trends and co-development deals.
  • Excel data sheet with thousands of data points of the Alzheimer Drugs Market – level 4/5 segmentation
  • PDF report with the most relevant analysis cogently put together after exhaustive qualitative interviews and in-depth market study
  • Product mapping in excel for the Alzheimer Drugs products of all major market players

 

Target Audience

  • Raw Material Suppliers/ Buyers
  • Product Suppliers/ Buyers
  • Industry Investors/Investment Bankers
  • Education & Research Institutes
  • Research Professionals
  • Emerging Companies
  • Manufacturer

 

@Enquiry Before Buying https://www.wiseguyreports.com/enquiry/3792278-global-alzheimer-drugs-market-2018-2025

 

Major Key Points of Global Alzheimer Drugs Market

  1. GLOBAL ALZHEIMER DRUGS MARKET-SCOPE AND METHODOLOGY

1.1. Research Methodology

1.2. Scope of the market

  1. GLOBAL ALZHEIMER DRUGS MARKET –TRENDS AND DEVELOPMENTS

2.1. Key Market Trends and Developments in Alzheimer Drugs Market

  1. INDUSTRY ANALYSIS

3.1. Drivers

3.2. Restraints

3.3. Opportunity

3.4. Pricing Analysis

3.5. Regulation

3.6. Supply Chain Analysis

3.7. Reimbursement policies

3.8. Technological Advancements

3.9. PEST analysis

3.10. Porter’s Five Forces Analysis

  1. GLOBAL ALZHEIMER DRUGS MARKET SEGMENTATION

……………

  1. COMPETITIVE LANDSCAPE

6.1. Competitive Scenario

6.2. Heat Map Analysis

6.3. Product Benchmarking

  1. COMPANY PROFILES

7.1. Johnson & Johnson

7.2. GlaxoSmithKline plc

7.3. Janssen Pharmaceutical

7.4. Novartis International AG

7.5. Allergan plc.

7.6. Teva Pharmaceuticals ltd.

7.7. Eisai Co Ltd.

7.8. H Lundbeck A/S

7.9. Daiichi Sankyo Company, Limited

7.10. Merz Holding GmbH & Co KG

  1. Key companies to watch
  2. Emerging Companies
  3. APPENDIX

10.1. Sources

10.2. List of Tables

10.3. Expert Panel Validation

10.4. Disclaimer

10.5. Contact Us

 

About Us:

Wise Guy Reports is part of the Wise Guy Research Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe.

Contact Us:

NORAH TRENT                                                      

sales@wiseguyreports.com       

Ph: +1-646-845-9349 (US)                          

Ph: +44 208 133 9349 (UK)        

 

Sign up and submit a press release

Sponsored

Packaging Compliance Labs (PCL) Celebrates Site Expansion in Grand Rapids, MI

Novel Approach to Assessing Lung Function Enables Improved Detection, Diagnosis and Treatment Decisions in Subject Exposed to Military Burn Pits

U.S. Patent Office Grants Additional Patent Protection For  Exoskeleton Focal-Force Angioplasty Platform

U.S. Patent Office Grants Additional Patent Protection For Exoskeleton Focal-Force Angioplasty Platform

Reliefband® State of Nausea Study Reveals More Than Three-Quarters of Americans Are Prevented from Enjoying Life As a Result of Regular Nausea

Reliefband® State of Nausea Study Reveals More Than Three-Quarters of Americans Are Prevented from Enjoying Life As a Result of Regular Nausea

New AI-Powered Voice Controls Streamline Ultrasound Imaging with All Clarius Handheld Systems

New AI-Powered Voice Controls Streamline Ultrasound Imaging with All Clarius Handheld Systems

interviews & reviews
Automated Computer Assistant for Kidney Transplant Rejection Diagnostics: Interview with Study Authors

Automated Computer Assistant for Kidney Transplant Rejection Diagnostics: Interview with Study Authors

RF Technology for Health Monitoring: Michael Leabman, CTO of Movano Health

RF Technology for Health Monitoring: Michael Leabman, CTO of Movano Health

AI’s role in Healthcare: Exclusive Interview with Catherine Estrampes, President & CEO at GE Healthcare

AI’s role in Healthcare: Exclusive Interview with Catherine Estrampes, President & CEO at GE Healthcare

Digital Self-Neuromodulation Therapy for PTSD: Interview with Oded Kraft, CEO of GrayMatters Health

Digital Self-Neuromodulation Therapy for PTSD: Interview with Oded Kraft, CEO of GrayMatters Health

Levels Is Making Metabolism and Blood Glucose Tracking Accessible To Everyone

Levels Is Making Metabolism and Blood Glucose Tracking Accessible To Everyone

Imagene Profiles Cancer Biomarkers in Real Time

Imagene Profiles Cancer Biomarkers in Real Time

Empowering Stroke Survivors: Interview with Kirsten Carroll, CEO at Kandu Health

Empowering Stroke Survivors: Interview with Kirsten Carroll, CEO at Kandu Health

  • Subscribe
  • Contact us
  • Submit
  • About
  • Back to top
Medgadget

Medical technologies transform the world! Join us and see the progress in real time. At Medgadget, we report the latest technology news, interview leaders in the field, and file dispatches from medical events around the world since 2004.

  • About
  • Editorial policies
  • Contact
  • Terms of Service
  • Privacy
  • Submit press release
  • Advertise
© Medgadget, Inc. All rights reserved. | The Medical Revolution Will Be Blogged.
Please support this website by adding us to your whitelist in your ad blocker. Ads are what helps us bring you premium content! Thank you!
  • Facebook
  • Twitter
  • LinkedIn
  • Reddit
  • Email